Liberum Capital reaffirmed their buy rating on shares of Udg Healthcare (LON:UDG) in a report issued on Tuesday, ThisIsMoney.Co.Uk reports.
A number of other research analysts have also issued reports on UDG. Peel Hunt reiterated a buy rating on shares of Udg Healthcare in a research report on Tuesday, January 29th. Barclays upgraded Udg Healthcare to an overweight rating and reduced their price target for the stock from GBX 770 ($10.06) to GBX 720 ($9.41) in a research report on Thursday, April 4th. Finally, Numis Securities upgraded Udg Healthcare to a hold rating in a research report on Thursday, May 16th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company has an average rating of Buy and an average price target of GBX 780.57 ($10.20).
Shares of UDG stock opened at GBX 712 ($9.30) on Tuesday. The company has a quick ratio of 1.80, a current ratio of 2.02 and a debt-to-equity ratio of 27.53. Udg Healthcare has a 1 year low of GBX 545 ($7.12) and a 1 year high of GBX 950.50 ($12.42). The firm has a market cap of $1.77 billion and a price-to-earnings ratio of 474.67.
The firm also recently declared a dividend, which will be paid on Wednesday, June 26th. Shareholders of record on Thursday, May 30th will be given a dividend of $0.04 per share. The ex-dividend date is Thursday, May 30th. This represents a yield of 0.5%. Udg Healthcare’s dividend payout ratio (DPR) is presently 8.00%.
About Udg Healthcare
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services.
Read More: Green Investing
Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.